1. Home
  2. CDT vs OBLG Comparison

CDT vs OBLG Comparison

Compare CDT & OBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • OBLG
  • Stock Information
  • Founded
  • CDT 2019
  • OBLG 2000
  • Country
  • CDT United States
  • OBLG United States
  • Employees
  • CDT N/A
  • OBLG N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • OBLG Computer Software: Programming Data Processing
  • Sector
  • CDT Health Care
  • OBLG Technology
  • Exchange
  • CDT Nasdaq
  • OBLG Nasdaq
  • Market Cap
  • CDT 5.2M
  • OBLG 5.5M
  • IPO Year
  • CDT N/A
  • OBLG N/A
  • Fundamental
  • Price
  • CDT $1.93
  • OBLG $4.04
  • Analyst Decision
  • CDT
  • OBLG
  • Analyst Count
  • CDT 0
  • OBLG 0
  • Target Price
  • CDT N/A
  • OBLG N/A
  • AVG Volume (30 Days)
  • CDT 290.9K
  • OBLG 139.6K
  • Earning Date
  • CDT 08-11-2025
  • OBLG 08-06-2025
  • Dividend Yield
  • CDT N/A
  • OBLG N/A
  • EPS Growth
  • CDT N/A
  • OBLG N/A
  • EPS
  • CDT N/A
  • OBLG N/A
  • Revenue
  • CDT N/A
  • OBLG $2,374,000.00
  • Revenue This Year
  • CDT N/A
  • OBLG N/A
  • Revenue Next Year
  • CDT N/A
  • OBLG N/A
  • P/E Ratio
  • CDT N/A
  • OBLG N/A
  • Revenue Growth
  • CDT N/A
  • OBLG N/A
  • 52 Week Low
  • CDT $1.90
  • OBLG $1.91
  • 52 Week High
  • CDT $622.50
  • OBLG $7.20
  • Technical
  • Relative Strength Index (RSI)
  • CDT 28.61
  • OBLG 44.99
  • Support Level
  • CDT $1.94
  • OBLG $4.57
  • Resistance Level
  • CDT $2.31
  • OBLG $5.50
  • Average True Range (ATR)
  • CDT 0.16
  • OBLG 0.61
  • MACD
  • CDT 0.04
  • OBLG -0.11
  • Stochastic Oscillator
  • CDT 7.02
  • OBLG 21.08

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About OBLG Oblong Inc.

Oblong Inc is a provider of patented multi-stream collaboration products and managed services for network solutions and video collaboration. The company's flagship product Mezzanine is the technology platform that defines computing: simultaneous multi-user, multi-screen, multi-device, and multi-location for dynamic and immersive visual collaboration. Mezzanine transforms routine meetings and workflows into agile, engaging experiences by making data visible and accessible in a collaborative setting. The mezzanine enables multiple, concurrent pieces of content to be shared, manipulated, created, and captured across distance. It serves various industries including aerospace, consulting, executive search, broadcast media, technology, financial services, education, healthcare, and real estate.

Share on Social Networks: